In developing countries, infectious keratitis being the probable cause of preventable blindness, also have a varied epidemiological profile. This study was conducted to know the microbiological profile, risk factors, epidemiology and antimicrobial susceptibility pattern of bacteria isolated from patients with a corneal ulcers. A total of 193 patients who were clinically diagnosed with cases of infective keratitis in the Department of Ophthalmology were included in the study. The sample collected by an ophthalmologist was received in the Microbiology department. All the demographic details and relevant clinical data were noted. The bacterial identification and antimicrobial susceptibility were done using automated methods while the fungal identification was done using the conventional method (Vitek2 Compact system, BioMerieux). Out of 193 patients, 69% were male and 31% % were females. The Majority of cases were from the age group 41- 50 years. Of 193 cases, 83 (43%) showed microbial etiology in culture. Of 83 culture positive cases, 55 (66.3%) were fungal and 28 (33.7%) were bacterial. The most common isolated fungus was Fusarium species detected in 24 (28.9%) cases followed by Aspergillus species in 14 (16.8%) cases. Gram positive bacteria were predominantly isolated from cases of infective keratitis. Staphylococcus aureus was the most common isolated bacteria in 12 (14.4%) out of 83 positive cases followed by Coagulase negative Staphylococcus. Pseudomonas aeruginosa was the most common Gram negative bacteria isolated from the cases. Among the topical antimicrobials, both Gram positive bacteria as well as Gram negative bacteria showed maximum sensitivity to levofloxacin. Proper knowledge of the clinical presentation and etiological agents aided with microbiological examination is necessary in order to effectively treat corneal ulcers and prevent further complications that can lead to blindness.
Non-fermenting gram-negative bacteria (NFGNB) endeavouring as major pathogen in infectious disease, predominantly in urinary tract infection (UTI) and increased resistance in NFGNB are matter of concern. This study aimed to evaluate the frequency of NFGNB, antibiotics resistance pattern, plasmid profiling, and antibacterial efficacy of Moringa oleifera against NFGNB. NFGNB were isolated from clinically suspected UTI patients. Identification of isolates and their antibiotics sensitivity pattern were analyzed according to conventional method, and Vitek 2 automated system. Moreover, NFGNB were evaluated for biofilm production and presence of plasmid. Furthermore, antibacterial activity of Moringa oleifera was evaluated against NFGNB. P. aeruginosa (86.0%), and A. baumannii (10.0%) were the most frequent NFGNB followed by Providencia rettgeri 2.0%, Stenotrophomonas maltophilia 1.0%, myroides species 1.0%. 68.6% P. aeruginosa and 60.0% A. baumannii were biofilm producers whereas imipenem and meropenem were the most effective antibiotics. Isolated NFGNB showed multiple bands of plasmid. Furthermore, Moringa oleifera leaves extract showed antibacterial activity against tested NFGNB. MDR-NFGNB presents challenges in treatment and Moringa oleifera leaf extract may be used as an alternative medicine. However, the therapeutic role of specific ingredients present in extract needs further investigation and purification.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.